The new drug, Latuda (lah-TOO-dah, lurasidone), will compete in a crowded market of "atypical" antipsychotics (Zyprexa, Abilify, etc)
September 2012
The new drug, Latuda (lah-TOO-dah, lurasidone), will compete in a crowded market of "atypical" antipsychotics (Zyprexa, Abilify, etc).
Atypicals are gaining popularity since prescribers are using them for bipolar disorder, depression, and autism...not just psychosis and schizophrenia.
Latuda is now the NINTH oral atypical antipsychotic.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote